Allergan expands Refresh eye treatment portfolio

7 Oct 2019

A trifecta of relief formulated with HydroCell technology offers new artificial tear options for patients suffering from eye dryness.

Allergan has launched three new over-the-counter (OTC) Refresh Relieva products: Refresh Relieva; Refresh Relieva PF (preservative-free) multidose; and Refresh Relieva for Contacts.

Allergan expands Refresh eye treatment portfolio

This new line of artificial tear formulations available in preserved, preservative-free multidose, and a formula designed for contact lens wearers, are specially formulated to relieve discomfort due to eye dryness and to prevent further irritation. Refresh, a doctor recommended brand of artificial tears, continues to expand its portfolio by offering the only family of products in the US with carboxymethylcellulose (CMC), hyaluronic acid (HA, an inactive ingredient), glycerin, and HydroCell technology - Allergan's proprietary sodium chloride (NaCl) free, glycerin-based solution that enables hydration and maintains the volume of cells on the ocular surface.

"We are pleased to expand our robust artificial tear portfolio with Refresh Relieva products as we continue to exemplify our commitment to innovation in eye care. This brand-new line provides doctors and patients with three unique options to treat patients' individual needs when it comes to dry, irritated eyes and contact lens dryness," said Jag Dosanjh, Senior Vice President, Allergan US Eye Care. "With Refresh Relieva for Contacts, contact lens patients now have a new option. As the number one selling brand in preservative-free artificial tears, it was also important to us to introduce Refresh Relieva in a new, convenient preservative-free bottle. Now patients can enjoy the convenience of a multidose bottle with all the benefits of being preservative-free."

Over 26 million people in the US suffer from symptoms of eye dryness, including irritation, burning, dryness, and discomfort. Eye dryness can be caused by advanced age, contact lens wear, certain medications, other medical conditions, or environmental factors. Studies show Refresh Relieva products improve the symptoms of eye dryness in patients, with a low incidence of blur upon installation.

70% of patients reported no blur when Refresh Relieva and Refresh Relieva for Contacts was first applied.

"As eye dryness varies for each patient, I'm excited to have three new artificial tear treatment options since we know that one size doesn't fit all for patients," said Milton Hom, OD. "Different patients have different needs and Refresh Relieva provides the diversity to satisfy more patients. With a low-blur formula and HydroCell technology Refresh Relieva will be my preferred artificial tear."

Read More

Related categories

Related tags

Market News

Related news

Funding to accelerate delivery of Univercells' vaccine portfolio

Funding to accelerate delivery of Univercells' vaccine portfolio

11 Oct 2019

European financing to support Univercells’ R&D investments to develop four essential and undersupplied global health vaccines to be produced at affordable prices, high quality and large volumes.

Read more 
Industrial-scale manufacture of therapeutic exosomes

Industrial-scale manufacture of therapeutic exosomes

10 Oct 2019

Coordinated purification process development service accelerates progress to clinical trials, and scale-up manufacturing.

Read more 
Janssen opens new biomanufacturing building in Ireland

Janssen opens new biomanufacturing building in Ireland

8 Oct 2019

Expansion creates 200 new full-time jobs and increases the company’s production capacity by an additional 19,100 m2.

Read more 
BASF and Biomillenia join forces in microbiome research to promote healthy skin

BASF and Biomillenia join forces in microbiome research to promote healthy skin

7 Oct 2019

Research aims to identify novel dermocosmetic active ingredients via unique microbiome-on-a-chip technology.

Read more 
BASF strengthens biotechnology footprint to enter natural F&F ingredients market

BASF strengthens biotechnology footprint to enter natural F&F ingredients market

3 Oct 2019

Market entrance with biotech-based natural vanillin, valencene and nootkatone.

Read more 
Unidose device approved for Tosymra sumatriptan spray

Unidose device approved for Tosymra sumatriptan spray

3 Oct 2019

Provides migraine sufferers with a convenient, patient-friendly delivery approach.

Read more 
One-stop-platform for plant-based nutraceuticals

One-stop-platform for plant-based nutraceuticals

2 Oct 2019

In 2020, nutra brands will look to ensure they have plant-based options across all product classes with many actively looking to move entire portfolios plant-based.

Read more 
BASF's new bioactive ingredient the wellness elixir for healthy skin

BASF's new bioactive ingredient the wellness elixir for healthy skin

1 Oct 2019

The active ingredient is a 100% natural extract from the chaga mushroom, obtained using an innovative eco-friendly technology: subcritical water extraction.

Read more 
Arctoris secures funding to advance novel robotic drug discovery platform

Arctoris secures funding to advance novel robotic drug discovery platform

1 Oct 2019

Platform will enable scientists and biotechnology entrepreneurs worldwide to make discoveries faster and more efficiently,

Read more 
Industry on the brink of a new age of smart pharma manufacturing

Industry on the brink of a new age of smart pharma manufacturing

27 Sep 2019

Report predicts tomorrow’s biggest industry winners will need to invest now ahead of the curve.

Read more